Skip to content

Contact +44 (0) 20 7060 7474 email us

Biotechnology

Antibiotics

Global Trends

Publication Date November 2009
Publisher BizAcumen
Product Type Report
Pages 395
ISBN Number not applicable
Product Code BIZ00113

Price

£1,980.00
approximately: $2,998 | €2,210

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Long-term growth in the global antibiotics market would be affected by two major factors - antibiotic resistance and generic competition. Antibiotic resistance, which compels reduction in the usage of antibiotics, represents the primary market inhibitor. In recent times, there has been a decline in antibiotic prescriptions for respiratory related infections. Another factor that could have a strong bearing on the market is the rising generic competition.

These and other market data and trends are presented in "Antibiotics: Global Trends" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

  • 1.Methodology
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Quantitative Techniques & Reporting Level
  • 2.Global Market Overview and Outlook
    • Antibiotic Resistance and Generic Competition to Impact Long Term Growth
  • 3.Market Dynamics
    • Anti-Bacterials Segment Drives Global Anti-Infectives Market
    • Antibiotic Resistance - A Primary Growth Inhibitor
    • Antibiotic-Resistant Bacteria by Type
    • Patent Expiries Commoditize Antibiotics
    • Patent Expiries of Leading Drugs in The Current and Future
    • Anti-Mrsa Antibiotics Find Their Way
    • Key Antibiotics in Pipeline
  • 4.Competition
    • Highly Competitive Market
    • Glaxosmithkline - The Undisputed Leader of Penicillin Market
    • Glaxosmithkline Leads Cephalosporin Market
    • Pfizer Dominates Macrolides Market
    • Levaquin/Tavanic - The Most Preferred Quinolone Antibiotic
    • Merck Rules Carbapenems Market
  • 5.Product Facts
    • Penicillin
    • Cephalosporins
    • Macrolides
    • Quinolones
    • Carbapenems
    • Other Antibiotics
    • Aminoglycosides
    • Tetracyclines
    • Sulfonamides
    • Mupirocin
    • Glycopeptides
    • Synercid
    • Oxazolidinones
    • Linezolid
  • 6.Research Findings
    • Cephalosporins Effective When Compared to Penicillin
    • Fda Bans Baytril Antibiotic for Chickens
    • Erythromycin along with Some Specific Drugs Increase Risk of Sudden Death
    • Rise in Usage of Quinolones for Urinary Tract Infections Leads to Drug Resistance
  • 7.Corporate Developments
  • 3i to Buy Alpharma Unit
    • Ncpc to Acquire Stake in Dsm's Antibiotics Division
    • Ull Establishes New Antibiotics Unit in Himachal Pradesh
    • Biocat to Expand Presence in The Indian Market
    • Prwt Acquires Cherokee Chemical Unit from Merck
    • Cspc Joins Hands with Indonesian Firms
    • Mit Scientists Develop A New Antibiotic, Rhodostreptomycin
    • Watson Pharma Introduces Biaxin Xl's Generic Version
    • Middlebrook Obtains Nda Approval for Moxatag/li>
    • Nisshin-Kyorin to Merge with Kyorin Pharmaceutical
    • Schering-Plough Acquires Organon Biosciences
    • Gsk & Anacor Partner for Boron Chemistry- Based Antibiotics and Antivirals
    • Iroko Bags Canadian Rights to Vancocin
    • Cubist Licenses Cubicin Rights to Merck
    • Sagent Partners with Astral to Develop Injectable Antibiotics
    • Mr Healthcare to Manufacture New Antibiotics & Medicines
    • Livzon Synthetic to Acquire Antibiotic Intermediate from Jiaozuo
    • C&o Pharmaceutical to Distribute Meiact in China
    • Bioton Signs Deal to Market Antibiotics in Russia
    • Toyama Gains Marketing Approval for Geninax in Japan
    • Forest Laboratories Acquires Cerexa
    • Oscient Modifies Licensing Agreement with Lg Life Sciences
    • Orchid Sign Licensing & Distribution Pact with Actavis
    • Forest Laboratories Revokes Partnership with Replidyne
    • Sri and Blanca Collaborate to Develop & Test Carbacephem
    • Astrazeneca to Expand Research Center for Antibiotics
    • Jade Pharmaceutical Begins Levofloxacin's Production in China
    • Reyoung to Start Antibiotic Production at New Facility
    • Toyama Begins T-705 Clinical Trials
    • Smpc for Sanofi-Aventis' Ketek Updated
    • Lupin Receives Approval for Cefpodoxime Proxetil Antibiotic Tablets in France
    • Antibiotice Plans to Infuse Funds for Antibiotics Production
    • UAE Approves Pfizer's Zithromax Sd
    • Toyama Launches New Garenoxacin Quinolone Antibiotic
    • Wockhardt to Introduce Cefprozil in The US
    • Msd India Launches Invanza in India
    • Orchid Chemicals to Introduce Three New Drugs in The US
    • Dusa Pharmaceuticals Releases Clindareach/li>
    • Mylan Releases Cipro's Generic Version
    • Macrolide Antibiotic Developed in The US
    • University of Michigan Devises Nmr Spectroscopy for Antibiotics
    • Glycopeptide-Cephalosporin Antibiotics Developed in The US
    • Neosil Tests Neo 101 Antibiotic
    • New Antibiotic Developed by Canadian Inventors
    • Abbott Canada Releases Factive Antibiotic Tablets in Canada
    • Penicillin Binding Protein Found in Japan
    • Venus Remedies Releases Mucomelt-Forte
    • J&jprd Seeks Fda Approval for Doripenem Antibiotic
    • J&jprd Seeks Fda Approval for Investigational Antibiotic,Ceftobiprole
    • Gsk Receives Approval for Altargo in Europe
    • Apl Receives Fda Approval for Cefpodoxime Proxetil
    • Cubist Receives Approval to Market Cubicin in Canada
    • Cubist Obtains Approval to Market Cubicin for Added Indications in Eu
    • Cubist Gains Approval for Cubicin in Taiwan and South Korea
    • Cethromycin Achieves Fda's Orphan Drug Designation
  • 8.Major Players
    • Abbott Laboratories (USA)
    • Bayer Healthcare Ag (Germany)
    • Bristol-Myers Squibb Co. (USA)
    • Cubist Pharmaceuticals, Inc. (USA)
    • Daiichi Sankyo Company, Limited (Japan)
    • Eli Lilly and Co. (USA)
    • Glaxosmithkline Plc (UK)
    • Johnson & Johnson (USA)
    • Kyorin Pharmaceutical Co., Ltd. (Japan)
    • Lg Life Sciences Limited (Korea)
    • MiddlebrookPharmaceuticals, Inc. (USA)
    • Novartis Ag (Switzerland)
    • Pfizer Inc. (USA)
    • Pliva D.D. (Croatia)
    • Roche (Switzerland)
    • Sanofi-Aventis Sa (France)
    • Takeda Pharmaceutical Company, Ltd. (Japan)
    • Toyama Chemical Co., Ltd. (Japan)
    • Wyeth Pharmaceuticals, Inc. (USA)
  • 9.Global Market Analytics
  • 10.The United States
    • Competition
  • 11.Canada
  • 12.Japan
  • 13.Europe
    • A.France
    • B.Germany
    • C.Italy
    • D.The United Kingdom
    • E.Spain
    • F.Rest of Europe
  • 14.Asia-Pacific
    • India
    • Rising Prices of Penicillin G to Affect Antibiotics Production
  • 15.Rest of World
  • Exhibits
    • Table 1: Percentage Breakdown of Leading Antibiotics Manufacturer Value Sales in The World -
    • Table 2: Percentage Breakdown of Leading Antibiotics Manufacturers within Penicillin Class in The World -
    • Table 3: Percentage Breakdown of Leading Antibiotics Manufacturers within Cephalosporin Class in The World -
    • Table 4: Percentage Breakdown of Leading Antibiotics Manufacturers within Macrolide Class in The World -
    • Table 5: Percentage Breakdown of Leading Antibiotics Manufacturers within Quinolone Class in The World -
    • Table 6: Percentage Breakdown of Leading Antibiotics Manufacturers within Carbapenem Class in The World -
    • Table 7: Global Antibiotics Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 8: Percentage Breakdown of Global Antibiotics Market by Region for The Years 2008 &
    • Table 9: Global Penicillin Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 10: Percentage Breakdown of Global Penicillin Market by Region for The Years 2008 &
    • Table 11: Global Cephalosporin Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 12: Percentage Breakdown of Global Cephalosporin Market by Region for The Years 2008 &
    • Table 13: Global Macrolide Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 14: Percentage Breakdown of Global Macrolide Market by Region for The Years 2008 &
    • Table 15: Global Quinolones Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 16: Percentage Breakdown of Global Quinolones Market by Region for The Years 2008 &
    • Table 17: Global Carbapenems Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 18: Percentage Breakdown of Global Carbapenems Market by Region for The Years 2008 &
    • Table 19: Global Other Antibiotics Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 20: Percentage Breakdown of Global Other Antibiotics Market by Region for The Years 2008 &
    • Table 21: Percentage Breakdown of Leading Antibiotics Manufacturer Value Sales in The US -
    • Table 22: Antibiotics Market by Segment in The US: 2007-2015 (Sales in US$ Million)
    • Table 23: Percentage Breakdown of Antibiotics Market by Segment in The US for The Years 2008 &
    • Table 24: Antibiotics Market by Segment in Canada: 2007-2015 (Sales in US$ Million)
    • Table 25: Percentage Breakdown of Antibiotics Market by Segment in Canada for The Years 2008 &
    • Table 26: Antibiotics Market by Segment in Japan: 2007-2015 (Sales in US$ Million)
    • Table 27: Percentage Breakdown of Antibiotics Market by Segment in Japan for The Years 2008 &
    • Table 28: Antibiotics Market by Region in Europe: 2007-2015 (Sales in US$ Million)
    • Table 29: Percentage Breakdown of Antibiotics Market by Region in Europe for The Years 2008 &
    • Table 30: Antibiotics Market by Segment in Europe: 2007-2015 (Sales in US$ Million)
    • Table 31: Percentage Breakdown of Antibiotics Market by Segment in Europe for The Years 2008 &
    • Table 32: Antibiotics Market by Segment in France: 2007-2015 (Sales in US$ Million)
    • Table 33: Percentage Breakdown of Antibiotics Market by Segment in France for The Years 2008 &
    • Table 34: Antibiotics Market by Segment in Germany: 2007-2015 (Sales in US$ Million)
    • Table 35: Percentage Breakdown of Antibiotics Market by Segment in Germany for The Years 2008 &
    • Table 36: Antibiotics Market by Segment in Italy: 2007-2015 (Sales in US$ Million)
    • Table 37: Percentage Breakdown of Antibiotics Market by Segment in Italy for The Years 2008 &
    • Table 38: Antibiotics Market by Segment in The UK: 2007-2015 (Sales in US$ Million)
    • Table 39: Percentage Breakdown of Antibiotics Market by Segment in The UK for The Years 2008 &
    • Table 40: Antibiotics Market by Segment in Spain: 2007-2015 (Sales in US$ Million)
    • Table 41: Percentage Breakdown of Antibiotics Market by Segment in Spain for The Years 2008 &
    • Table 42: Antibiotics Market by Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
    • Table 43: Percentage Breakdown of Antibiotics Market by Segment in Rest of Europe for The Years 2008 &
    • Table 44: Antibiotics Market by Segment in Asia Pacific: 2007-2015 (Sales in US$ Million)
    • Table 45: Percentage Breakdown of Antibiotics Market by Segment in Asia Pacific for The Years 2008 &
    • Table 46: Antibiotics Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million)
    • Table 47: Percentage Breakdown of Antibiotics Market by Segment in Rest of World for The Years 2008 &
  • Companies Profiled